@SusanStipa

🔬 30+ yrs in pharma manufacturing & mom of 4 🌱 Founder & CEO @phylloceuticals: plant-based biologic medicine ↓ Learn more

 Pennsylvania
link.me/susan_stipa
Joined August 2009
  • Tweets436
  • Following481
  • Followers141
36Media
Cohort 11 at University Science Center Philadelphia. Five days, five investors in residence, 111 companies through this program.
1
9
What to ask your doctor. Even if they don't know the answer yet.
2
12
$300 billion in drugs go off-patent by 2030. Here's what that actually means.
1
29
Where the cost of a biologic actually comes from. And where that will change soon.
1
38
You looked up mRNA. Now ask about this.
6
"I'm the chief medical officer of my family." If that's you, this is for you.
3
What happens when you ask your doctor about plant-based biologics. And why you should ask anyway.
11
Why duckweed (Yes. The plant on the pond.)
1
1
7
We signed our first customer. We're making recombinant grade research proteins for an anti-parvo vaccine.
2
23
What fetal bovine serum is and why it's in your biologic medication.
1
3
Herbal supplement vs. plant-made biologics. Here's why they're NOT the same thing.
1
6
Why biologic manufacturing hasn't changed in 30 years... and what just changed that.
9
Not all cells used to manufacture biologic medicine are created equal, and plant cell biologics like Lemna may be the most efficient option the industry hasn't scaled yet.
2
23
Most biologic medicine is made inside living animal cells, and the cost of making it safe for humans gets passed directly to patients. Plant cell manufacturing could change that.
1
10
Hi, I'm Susan. Biotech founder, former pharmaceutical manufacturing executive, and breast cancer survivor. I spent 30 years inside this industry, and I'm proud of that work. It has saved millions of lives, including mine. But when you know what you know, you can't stay quiet.
1
225
Check out my latest article: Reframing Creative Time as Your Competitive Edge linkedin.com/pulse/reframing… via @LinkedIn

Reframing Creative Time as Your Competitive Edge

Here is a thought for my fellow entrepreneurs. I sit here, pen in hand or often, keyboard near my coffee, about to create the next chapter in a book I’ve been trying to write for two years.

linkedin.com
1
19
It’s important that you understand what happened last night. Last night, Stephen Colbert interviewed Democratic Texas Senate candidate James Talarico, a candidate who, by all accounts, is on track in the polls to flip Texas blue. In response, Trump’s FCC reportedly threatened CBS if the interview aired. CBS caved and pulled the segment, citing “financial reasons.” In modern American history, no president has been more hostile to free speech than Donald Trump. But censorship always backfires. Here’s the full segment Trump didn’t want you to see.
3,255
35,323
1,258
125,136
3,798,296
Susan Stipa retweeted
Caitlin Rivers
@cmyeatonFeb 11
This is troubling for multiple reasons, but a big one is companies won’t invest in R&D and clinical trials if they don’t think they can get a fair regulatory review—which is at the end of a long and extremely expensive process.
https://www.nytimes.com/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html?unlocked_article_code=1.LVA.40bY.2lblDMAcJ3oH&smid=url-share

ALT https://www.nytimes.com/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html?unlocked_article_code=1.LVA.40bY.2lblDMAcJ3oH&smid=url-share

17
807
49
2,512
77,507
The Dial Press randomhousebooks.com/imprint… my new favorite resource for heart-centric reads
1
17
All around the mulberry bush, the CEO chased the funding…. Today: #TAAC8 pitch Tomorrow: MidAtlantic Capital conference, live! #PACT #Philadelphia #Biotechnology #MAAC2025
20
Load more